Publication

Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats

Learn how phospholipid‑based formulations significantly increased lutein and zeaxanthin exposure versus MCT oil, analysed using…

CertaraDecember 2, 2025

Publication

Dosing Optimization of Lamotrigine in Peripregnancy Epilepsy Through PopPK Modelling and Simulation

Find out how PopPK modelling shows major gestational changes in lamotrigine clearance and supports precise…

CertaraNovember 20, 2025

Publication

Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration data.

Explore how Phoenix NLME simulations highlight variability in perioperative ibrutinib exposure and the impact of…

CertaraNovember 20, 2025

Blog

ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™

At ACoP 2025, Certara showcased innovation with the launch of Certara IQ™ and Phoenix® Cloud,…

CertaraNovember 13, 2025

On-Demand Webinar

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…

CertaraNovember 13, 2025

Publication

Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk

Discover how PBPK and clinical data show low infant exposure to doravirine during breastfeeding, supported…

CertaraNovember 6, 2025

Press Release

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara has released TFL studio, a module in its cloud-native PK/PD software, Phoenix Cloud, to…

CertaraNovember 4, 2025

Publication

Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy Volunteers

See how subcutaneous rhSOD shows sustained exposure and favourable safety compared with IV dosing, analysed…

CertaraOctober 18, 2025

Publication

Pharmacokinetics and Safety of Fospropofol Disodium for Injection in Subjects with Hepatic Impairment Compared with Healthy Matched Controls: A Prospective Cohort Study

Learn how faster fospropofol elimination but slower propofol clearance can help hepatic impairment, analysed using…

CertaraOctober 17, 2025

Blog

Streamlining PK/PD reporting: A smarter approach to generating tables, figures and listings

Discover how TFL Studio accelerates PK/PD reporting. Create audit-ready tables, figures, and listings faster with…

CertaraOctober 16, 2025

Certara Products – Phoenix

Comparative Pharmacokinetics of Lutein and Zeaxanthin from Phospholipid, Liposomal, and MCT Formulations in SD Rats

Dosing Optimization of Lamotrigine in Peripregnancy Epilepsy Through PopPK Modelling and Simulation

Simulation of perioperative Ibrutinib withdrawal using a population pharmacokinetic model and sparse clinical concentration data.

ACoP 2025 insights: Scaling the future of QSP modeling with Certara IQ™

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Physiologically based pharmacokinetic model combined with a clinical lactation study to determine doravirine concentrations in human breastmilk

Certara Automates Scientific Workflows with Phoenix® Cloud

Randomized, Double-Blind, Phase I Pharmacokinetic Study of Subcutaneous Recombinant Human Superoxide Dismutase (rhSOD) in Healthy Volunteers

Pharmacokinetics and Safety of Fospropofol Disodium for Injection in Subjects with Hepatic Impairment Compared with Healthy Matched Controls: A Prospective Cohort Study

Streamlining PK/PD reporting: A smarter approach to generating tables, figures and listings

Newsletter sign up

Quick links

Solutions

Contact